Latest
-
Precision Cancer Medicines for Colon Cancer
Genomic testing identifies genetic targets that can be treated with precision cancer medicines avoiding chemotherapy
-
FDA Approves Tucatinib (Tukysa) Combination as Maintenance Treatment for HER2-Positive Advanced Breast Cancer
A new FDA-approved maintenance option may help people with HER2-positive advanced breast cancer keep their cancer under control longer. Learn how adding tucatinib (Tukysa) to trastuzumab and pertuzumab delayed cancer progression—and what the approval could mean for patients after initial treatment.
Welcome to CancerConnect
CancerConnect is a unique resource that brings patients, caregivers, advocates and experts together – individuals benefit from a blend of expert-authored news and educational programming alongside a robust social network, providing insight into symptoms, diagnosis, and treatment and the support of other individuals being treated at some of the best cancer centers. CancerConnect offers users expert authored clinically-reviewed information and the perspective of their peers in a safe, objective space, helping to ensure they become empowered in their healthcare journey. Search the over 7000 articles on the management of cancer.
